ALAMAST
LOE ApproachingNDAOPHTHALMICSOLUTION/DROPSPriority Review
Approved
Sep 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 8h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ALAMAST is an ophthalmic solution approved in 1999 for treatment of allergic conjunctivitis. The product is a small-molecule eye drop formulation delivered directly to ocular tissues. Mechanism of action and specific indications are not publicly detailed in available data.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30%), signaling need for defensive commercial strategies and potential team restructuring as LOE approaches.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ALAMAST represents a late-lifecycle product requiring strong expertise in manufacturing optimization, regulatory compliance, and international market management across Asia-Pacific, Europe, and emerging markets. Career growth on this product emphasizes operational resilience, supply chain stability, and commercial defense rather than innovation or expansion.
[Singapore] Global Safety Vigilance Risk Management Lead
Worked on ALAMAST at Santen? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.